S&P 500
(-0.60%) 5 235.48 points
Dow Jones
(-0.86%) 38 111 points
Nasdaq
(-1.08%) 16 737 points
Oil
(-0.35%) $77.64
Gas
(-0.82%) $2.55
Gold
(-0.11%) $2 363.80
Silver
(-1.46%) $31.08
Platinum
(-0.78%) $1 029.90
USD/EUR
(0.16%) $0.924
USD/NOK
(0.11%) $10.55
USD/GBP
(0.09%) $0.786
USD/RUB
(0.00%) $90.27

Realtime updates for MedPacto, Inc. [235980.KQ]

Exchange: KOSDAQ
Last Updated31 May 2024 @ 00:38

-2.62% KRW 8 560.00

Live Chart Being Loaded With Signals

Commentary (31 May 2024 @ 00:38):

MedPacto, Inc., a drug discovery and development company, develops and delivers therapeutics targeting cancer and autoimmune diseases in South Korea. The company is developing ME-1601mAb that targets BSP1 for cancers; MS-1601A that targets TRG1 for cancers and autoimmune diseases; and vactosertib for solid tumors...

Stats
Today's Volume 262 999
Average Volume 571 580
Market Cap 310.77B
EPS KRW0 ( 2024-05-09 )
Next earnings date ( KRW0 ) 2024-08-07
Last Dividend KRW0 ( N/A )
Next Dividend KRW0 ( N/A )
P/E 0
ATR14 KRW14.04 (0.16%)

Volume Correlation

Long: 0.12 (neutral)
Short: 0.06 (neutral)
Signal:(50.685) Neutral

MedPacto, Inc. Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

MedPacto, Inc. Correlation - Currency/Commodity

The country flag 0.29
( neutral )
The country flag 0.55
( weak )
The country flag 0.09
( neutral )
The country flag -0.50
( weak negative )
The country flag -0.10
( neutral )
The country flag -0.35
( neutral )

MedPacto, Inc. Financials

Annual 2023
Revenue: KRW0
Gross Profit: KRW-1.83B (0.00 %)
EPS: KRW-1 664.87
FY 2023
Revenue: KRW0
Gross Profit: KRW-1.83B (0.00 %)
EPS: KRW-1 664.87
FY 2022
Revenue: KRW0
Gross Profit: KRW-1.87B (0.00 %)
EPS: KRW-1 455.80

Financial Reports:

No articles found.

MedPacto, Inc. Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

MedPacto, Inc.

MedPacto, Inc., a drug discovery and development company, develops and delivers therapeutics targeting cancer and autoimmune diseases in South Korea. The company is developing ME-1601mAb that targets BSP1 for cancers; MS-1601A that targets TRG1 for cancers and autoimmune diseases; and vactosertib for solid tumors. MedPacto, Inc. is based in Seoul, South Korea.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators